SLVCX
Price
$18.12
Change
+$0.08 (+0.44%)
Updated
Oct 17 closing price
Net Assets
17.61M
VIVAX
Price
$72.44
Change
+$0.36 (+0.50%)
Updated
Oct 17 closing price
Net Assets
207.8B
Interact to see
Advertisement

SLVCX vs VIVAX

Header iconSLVCX vs VIVAX Comparison
Open Charts SLVCX vs VIVAXBanner chart's image
Saratoga Large Capitalization Value C
Price$18.12
Change+$0.08 (+0.44%)
VolumeN/A
Net Assets17.61M
Vanguard Value Index I
Price$72.44
Change+$0.36 (+0.50%)
VolumeN/A
Net Assets207.8B
SLVCX vs VIVAX Comparison Chart in %
View a ticker or compare two or three
VS
SLVCX vs. VIVAX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLVCX is a Hold and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 208B vs. SLVCX (17.6M). VIVAX pays higher dividends than SLVCX: VIVAX (1.97) vs SLVCX (0.00). SLVCX was incepted earlier than VIVAX: SLVCX (27 years) vs VIVAX (33 years). SLVCX (2.87) is less costly to investors than VIVAX (0.17). SLVCX is a more actively managed with annual turnover of: 83.00 vs. VIVAX (9.00). SLVCX has a lower initial minimum investment than VIVAX: SLVCX (250) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 4.63 vs. SLVCX (-14.45). VIVAX return over 5 years is better than : 71.78 vs. SLVCX (0.33).
SLVCXVIVAXSLVCX / VIVAX
Total Expense Ratio2.870.171,688%
Annual Report Gross Expense Ratio2.870.171,688%
Fund Existence27 years33 years-
Gain YTD10.4889.738108%
Front LoadN/AN/A-
Min. Initial Investment25030008%
Min. Initial Investment IRAN/AN/A-
Net Assets17.6M208B0%
Annual Yield % from dividends0.001.97-
Returns for 1 year-14.454.63-312%
Returns for 3 years2.0342.995%
Returns for 5 years0.3371.780%
Returns for 10 years1.40129.451%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NNNN29.001.28
+4.62%
Anbio Biotechnology
SPGI473.191.14
+0.24%
S&P Global
GATX172.02-2.41
-1.38%
GATX Corp
NMRA1.73-0.05
-2.81%
Neumora Therapeutics
MYO1.03-0.05
-4.63%
Myomo